2019
DOI: 10.1007/s12017-019-08564-4
|View full text |Cite
|
Sign up to set email alerts
|

Incidence and Clinical Features of TRPV4-Linked Axonal Neuropathies in a USA Cohort of Charcot–Marie–Tooth Disease Type 2

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 9 publications
(2 citation statements)
references
References 19 publications
0
2
0
Order By: Relevance
“…3E), CDSMA (congenital and sometimes accompanied by arthrogryposis), SPSMA (scapulopeoneal muscular atrophy), CMT2C (muscle weakness and sensory involvement) and dHMN (length-dependent condition and no sensory involvement) separately. Furthermore, a literature review of the clinical characteristics of CMT2C patients [3,4,7,[10][11][12][13][14][15][16][17] (Table 1) and SPSMA [3,9,13,[18][19][20][21] were performed (Table e-1). In the summary table, we showed that CMT2C might also have other manifestations in addition to nervous system involvement, such as vocal cord paralysis (37/48, 77%), hearing loss (12/42, 29%), and scoliosis (10/37, 27%).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…3E), CDSMA (congenital and sometimes accompanied by arthrogryposis), SPSMA (scapulopeoneal muscular atrophy), CMT2C (muscle weakness and sensory involvement) and dHMN (length-dependent condition and no sensory involvement) separately. Furthermore, a literature review of the clinical characteristics of CMT2C patients [3,4,7,[10][11][12][13][14][15][16][17] (Table 1) and SPSMA [3,9,13,[18][19][20][21] were performed (Table e-1). In the summary table, we showed that CMT2C might also have other manifestations in addition to nervous system involvement, such as vocal cord paralysis (37/48, 77%), hearing loss (12/42, 29%), and scoliosis (10/37, 27%).…”
Section: Discussionmentioning
confidence: 99%
“…3D). In addition, the R316C mutation was the most commonly change and was observed in dHMN [4], SPSMA [4,7,18] and CMT2C [7,10,11] patients. Only two patients with R316H mutation have been reported so far, manifesting CMT2C and dHMN, respectively.…”
Section: Discussionmentioning
confidence: 99%